Romy Younan1 and Georges El Hachem2*
1Department of Hematology and Medical Oncology, Mount Lebanon Hospital University Medical Center, Assistant Professor of Clinical Medicine Center at University of Balamand, Lebanon
2Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center, Associate Professor of Clinical Medicine Center at Saint George University of Beirut, Lebanon
*Corresponding Author: Georges El Hachem, Department of Hematology and Medical Oncology, Saint George Hospital University Medical Center, Associate Professor of Clinical Medicine Center at Saint George University of Beirut.
Received: May 13, 2025; Published: May 19, 2025
Artificial intelligence and IOT (internet of things) being the latest hype in our everyday applications of technology started to shape multiple sectors around us. From transportation to finance, education and social media, it is indeed growing by the day and torpedoed by the massive investment capabilities of tech firms and their insatiable appetite to explore new fields.
Citation: Romy Younan and Georges El Hachem. “Advances and Limitations of Artificial Intelligence in Healthcare: Oncology Perspective”.Acta Scientific Cancer Biology 9.1 (2025): 01.
Copyright: © 2025 Romy Younan and Georges El Hachem. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
